Related Experiment Videos
Long-term epidemiologic prediction of coronary disease. The Framingham experience
1Boston University School of Medicine, Evans Memorial Department of Clinical Research, University Hospital, Boston University Medical Center, Mass.
Insights
Atherosclerotic cardiovascular disease risk is compounded by multiple factors including lipids, blood pressure, and lifestyle. Comprehensive risk assessment and multifactorial prevention strategies are crucial for managing cardiovascular health effectively.
Area of Science:
- Cardiovascular Medicine
- Epidemiology
- Preventive Cardiology
Background:
- Atherosclerotic cardiovascular disease (ASCVD) is a multifactorial condition influenced by lipid deposition, hypertension, carbohydrate intolerance, and thrombogenesis.
- Epidemiologic research identifies key contributors including personal attributes, lifestyle habits, compromised coronary circulation, and host susceptibility.
- Individual risk factors like blood lipids, blood pressure, glucose tolerance, and fibrinogen interact, compounding overall risk.
Purpose of the Study:
- To synthesize the complex interplay of risk factors contributing to atherosclerotic cardiovascular disease.
- To highlight the importance of a composite risk assessment integrating multiple atherogenic attributes and preclinical indicators.
- To emphasize the necessity of multifactorial preventive strategies for optimal management of cardiovascular risk.
Main Methods:
- Epidemiologic research to identify atherogenic personal attributes and lifestyle factors.
- Analysis of the compounding effects of multiple risk factors (hypertension, hyperlipidemia, diabetes).
- Inclusion of preclinical indicators of silent myocardial ischemia (e.g., ECG abnormalities) in risk assessment.
- Development of quantitative risk prediction tools using multiple logistic risk formulations.
Main Results:
- Risk associated with hypertension, hyperlipidemia, or diabetes varies based on the presence and level of other risk factors.
- The total/HDL cholesterol ratio is a critical determinant of risk at a given total cholesterol level.
- Lifestyle factors (smoking, lack of exercise, obesity, diet) independently influence risk and modify risk factor levels.
- Preclinical indicators like ECG left ventricular hypertrophy and conduction abnormalities significantly augment risk.
- Office-based tools (handbooks, software) based on logistic risk formulations accurately predict disease risk in diverse populations.
Conclusions:
- Optimal prediction of cardiovascular disease risk requires quantitative synthesis of multiple risk factors.
- Multifactorial preventive management, including public health measures, health education, and targeted interventions for high-risk individuals, is essential.
- Preventive strategies must consider the synergistic effects of risk factors and preclinical indicators.
- Drug selection for managing hypertension, diabetes, and lipid disorders should consider their impact on the overall cardiovascular risk profile.
Abstract:
Atherosclerotic cardiovascular disease is a complex problem involving lipid deposition, pressure, rheologic forces, carbohydrate tolerance and thrombogenesis. The major contributors identified through epidemiologic research include atherogenic personal attributes, living habits which promote them, signs of a compromised coronary circulation and host susceptibility to these risk factors. Of the atherogenic risk attributes, such as blood lipids, blood pressure, glucose tolerance and fibrinogen, each independently contributes to risk, and the risk associated with any one is compounded by the presence of the others. The risk associated with hypertension, hyperlipidemia or diabetes varies widely depending on the level of associated risk factors. Also, at a given level of total cholesterol, risk is greatly affected by the total/HDL cholesterol ratio, which provides a practical means for assessing the two-way traffic of cholesterol. In addition, living habits, such as cigarette smoking or lack of exercise, can independently affect the risk associated with any of the atherogenic traits. These living habits, obesity and diet can also affect the level of atherogenic risk factors and must be taken into account in assessing risk and implementing preventive measures. Finally, preclinical indicators of silent myocardial ischemia greatly augment the risk associated with a poor cardiovascular risk profile. Hence, ECG left ventricular hypertrophy, blocked intraventricular conduction, repolarization abnormalities and abnormal response to exercise on monitoring must be taken into consideration. Optimal risk predictions require a quantitative synthesis of risk factors into a composite estimate. Handbooks, hand calculators and PC software have been devised for office use based on multiple logistic risk formulations. These have been shown to accurately predict disease risk in a variety of American population samples, in elderly as well as young coronary candidates. Preventive management as well as risk estimation should be multifactorial if optimal results are to be achieved. Preventive strategies should include public health measures to alter the ecology so as to shift the distribution of risk factors to a more favorable level, health education to enable people to protect their own health and preventive medicine for high-risk candidates. Greater skill must be developed to carry out such interventions. In selecting drugs to correct hypertension, diabetes and lipid disorders, it is important to choose agents which do not adversely affect the composite risk profile.